Literature DB >> 7934102

The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. Comparison between pN0 disease and pN2 disease.

T Yano1, H Yokoyama, T Inoue, H Asoh, K Tayama, E Takai, Y Ichinose.   

Abstract

In the present study, we assessed whether the pattern of postoperative recurrence of non-small-cell lung cancer differed between patients with pathologic N0 disease and those with pathologic N2 disease. We reviewed 231 patients with pathologic N0 disease and 63 with pathologic N2 disease, who had undergone a complete resection from 1980 to 1990, and investigated the first recurrence sites. Seventy-two patients with pathologic N0 disease and 52 with pathologic N2 disease were found to have had postoperative recurrence. Both pathologic N0 disease and pathologic N2 disease recur frequently in distant organs, and the ratio of distant metastasis to local recurrence did not differ between the two diseases. The brain, lung, and bone were the common initial metastatic sites in both pathologic N0 disease and pathologic N2 disease. The brain was the most frequent site of distant metastasis in patients with pathologic N0 disease, whereas, on the other hand, pulmonary metastasis was observed more frequently than brain metastasis in those with pathologic N2 disease. Despite histologic types, the presence of different patterns of initial metastatic sites between pathologic N0 and pathologic N2 diseases was observed. Our results suggest that the sites of metastasis after resection depend largely on such anatomic factors as drainage routes. Namely, in contrast to pathologic N0 disease, pathologic N2 disease has an additional drainage route, which is from the N2 nodes to the superior vena cava (pulmonary circulation). Therefore, the frequency of pulmonary metastasis may increase in patients with pathologic N2 disease.

Entities:  

Mesh:

Year:  1994        PMID: 7934102

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Rib metastasis appearing 8 years after surgery for lung cancer: report of a case.

Authors:  S Kase; K Sugio; T Yano; K Nishioka; K Yamazaki; T Okamoto; T Koga; M Yamaguchi; K Ondo; K Sugimachi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 2.  Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer.

Authors:  Tokujiro Yano; Tatsuro Okamoto; Seiichi Fukuyama; Yoshihiko Maehara
Journal:  World J Clin Oncol       Date:  2014-12-10

3.  Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.

Authors:  Holger Schirrmeister; Coskun Arslandemir; Gerhard Glatting; Regine Mayer-Steinacker; Martin Bommer; Karsten Dreinhöfer; Andreas Buck; Martin Hetzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-28       Impact factor: 9.236

Review 4.  Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Authors:  Andrea Caulo; Saeed Mirsadraee; Fabio Maggi; Lucia Leccisotti; Edwin J R van Beek; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2011-10-04       Impact factor: 5.315

5.  Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer.

Authors:  Takashi Kanou; Jiro Okami; Toshiteru Tokunaga; Daisuke Ishida; Hidenori Kuno; Masahiko Higashiyama
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

6.  Candidate genes and pathways associated with brain metastasis from lung cancer compared with lymph node metastasis.

Authors:  Xuelian Zhao; Nan Wang; Tungamirai Chidanguro; Huanyu Gu; Yi Li; Huiru Cao; Pushuai Wen; Fu Ren
Journal:  Exp Ther Med       Date:  2019-06-26       Impact factor: 2.447

7.  Commentary: Postrecurrence survival in patients with lung cancer after curative surgery warrants systematic investigation to optimize management strategies.

Authors:  Chi Sum Yuen; Michael Hsin
Journal:  JTCVS Open       Date:  2022-04-21

8.  Imaging of recurrent lung cancer.

Authors:  Naama R Bogot; Leslie E Quint
Journal:  Cancer Imaging       Date:  2004-03-04       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.